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IntroductIon Wegener’s granulomatosis (WG) 
is a primary necrotizing vasculitis of unknown 
etiology, characterized by the presence of an‑
tineutrophil cytoplasmic antibodies (ANCA).1 
Genetic association studies have suggested that 
the variability of T‑cell co‑stimulatory molecule 
receptor cytotoxic T‑lymphocyte antigen 4, inter‑
leukin‑10 gene and human leukocyte antigens 
system may predispose to WG.2,3 Elevated serum 
immunoglobulin E (IgE) levels have also been re‑
ported4,5 among immuno logical alterations in WG 
patients, but their relevance to the vasculitis has 
not been established. Serum IgE represents only 
to a minute fraction of immunoglobulins, and is 
mostly bound to the high affinity receptor (FcεRI) 
present on mast cells, basophils and eosinophils. 
The receptor occupied by allergen‑specific IgE 
molecules is responsible for anaphylaxis and pos‑
sibly can also modulate the immuno logical re‑
sponse, because it is expressed on antigen pre‑
senting cells.6 Moreover, the gene encoding for 
IgE‑binding α‑subunit of the FcεRI (FCER1A) 
maps to chromosome 1q21‑23, the region impli‑
cated in susceptibility to multiple auto immune 
disorders and/or allergy.7 Interestingly, altered ex‑
pression of FCER1A has been observed in patients 
with systemic lupus erythematosus.8
Working hypothesis We investigated common 
genetic variants of genes coding for α‑ (FCER1A) 
and β‑subunit (FCER1B) of FcεRI in WG. This ge‑
netic variability is located in the gene controlling 
region and was previously associated with elevat‑
ed serum IgE in allergic subjects9,10, however there 
were no studies performed in subjects with auto‑
immune diseases. We wondered if genetic vari‑
ability of these loci is correlated to quantitative 
inflammatory features in a moderately numerous 
but well characterized group of WG patients.
MaterIals and Methods 30 consecutive 
subjects diagnosed with WG were enrolled 
translatIonal MedIcIne
Genetic associations of variants of the high 
affinity receptor for immunoglobulin E 
in Wegener’s granulomatosis
Marek Sanak, Daniel P. Potaczek, Jan Sznajd, Jacek Musiał, Andrzej Szczeklik
Department of Internal Medicine, Jagiellonian University Medical College, Kraków, Poland
Correspondence to:
Prof. Marek Sanak, MD, PhD, 
II Katedra Chorób Wewnętrznych, 
Uniwersytet Jagieloński, Collegium 
Medicum, ul. Skawińska 
8, 31-066 Krakow, Poland, 
phone: +48-12-430-52-66, 
fax: +48-12-430-52-03, e-mail: 
mmsanak@cyf-kr.edu.pl
Received: February 9, 2009.
Accepted: February 10, 2009.
Conflict of inter est: none declared.
Pol Arch Med Wewn. 2009;  
119 (3): 170-174
Translated by Prof. Marek Sanak, 
MD, PhD
Copyright by Medycyna Praktyczna, 
Kraków 2009
abstract
Immunoglobulin E (IgE) and the high affinity IgE receptor (FcεRI) have been suggested to contrib‑
ute to the pathogenesis of auto immune disorders. Their role in Wegener’s granulomatosis (WG) 
are, however, poorly recognized. We sought a genetic association between laboratory markers for 
the disease, i.e. anti‑proteinase 3 antibodies (anti‑PR3), anti‑myeloperoxidase antibodies, anti‑cyclic 
citrullinated peptide antibodies, C‑reactive protein (CRP), C3c and C4 complement components, and 
total serum IgE levels in WG subjects with common genetic variants of FcεRI subunits. Anti‑PR3 and 
CRP and serum IgE levels showed significant associations, while complement components tended 
to be associated, with −18483A>C and/or –344C>T FCER1A (FcεRI α‑subunit gene) polymorphisms. 
Moreover, a correlation between –109T>C FCER1B (FcεRI β‑subunit gene) genotypes and serum IgE 
was observed. Both WG specific auto‑antibodies and other blood inflammatory markers displayed 
correlations with serum total IgE levels and genetic variants of the high affinity receptor for this 
immunoglobulin. This observation suggests a functional relantionship of FcεRI in the regulation 
of auto immune response observed in WG.
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by IIF (Euroimmun AG, Luebeck, Germany) using 
the HEp‑2 cell line and considered positive at ti‑
ter greater than 1:160. Serum complement com‑
ponents C3c and C4, rheumatoid factor (thresh‑
old 15 IU/ml), C‑reactive protein (CRP) and total 
serum IgE levels were measured by laser immu‑
nonephelometry (Dade Behring Marburg GmbH, 
Marburg, Germany). Anti‑cyclic citrullinated pep‑
tide antibodies (aCCP) were assessed using ELI‑
SA (Euroimmun AG, Luebeck, Germany; tresh‑
old 5 RU/ml).
Age was referred in years as a mean ± standard 
deviation. Because other para metric variables 
significantly deviated from the normal distri‑
bution; CRP, C3c, C4, anti‑PR3, anti‑MPO, aCCP 
levels were reported as median and 25th–75th per‑
centile. Comparisons of these para meters be‑
tween arbitrary genotype classes were done us‑
ing the non‑parametric Mann‑Whitney U‑test. 
Total serum IgE levels were log‑transformed and 
reported as log (IgE) mean ± standard deviation 
and compared between the groups using the un‑
paired Student’s t‑test. A p <0.05 was consid‑
ered significant.
results Genotypes for FCER1A and FCER1B 
were in Hardy‑Weinberg equilibrium and their 
frequencies did not differ from those published 
for Caucasians. The following frequencies were 
observed for FCER1A: −18483A>C (10 AA, 18 AC, 
2 CC), –344C>T (9 CC, 19 CT, 2 TT), –95T>C 
(13 TT, 16 TC, 1 CC), and for FCER1B –109T>C 
(12 TT, 13 TC, 5 CC).
Both, −18483A>C and –344C>T FCER1A poly‑
morphisms were related to total serum IgE and 
CRP (table 2). In addition, –18483A>C polymor‑
phism was associated with anti‑PR3 levels. C3c 
and/or C4 complement components showed 
a statistical trend for a correlation with both 
FCER1A variants. Total serum IgE levels were also 
associated with –109T>C FCER1B polymorphism. 
None of the listed above genetic variants was as‑
sociated with the severity of WG, assessed using 
a clinical symptoms scale. The FCER1A –95T>C 
genetic variant, which did not correlate with lab‑
oratory markers of WG, inter estingly showed 
a significant association with cardiovascular man‑
ifestations of WG; 78.6% carriers of –95C vari‑
ant (CC or TC) had cardiovascular symptoms, 
while in patients with –95TT genotype only 25% 
(p = 0.016).
suMMary Elevated total serum IgE levels have 
been already described in WG patients, howev‑
er, the specific role of IgE has not been discussed 
because increased bio synthesis of immunoglobu‑
lins commonly coexists auto immune inflamma‑
tion. In this preliminary report we confirmed that 
genetic variants of the high affinity receptor for 
IgE correlate with its levels, which was previous‑
ly demonstrated in allergic subjects.13 Moreover, 
the same receptor variants seem to have an im‑
pact on WG specific laboratory markers and on in‑
flammatory process of the disease.
to the study. A simple clinical symptoms assess‑
ment scale was used to record the systemic in‑
volvement by the disease. Patients characteristics 
are presented in table 1. All the patients gave writ‑
ten informed consent to participate in the study 
and the Jagiellonian University Ethics Commit‑
tee approved the study.
Laboratory measurements were performed 
in venous blood. The genotyping for FCER1A 
−18483A>C, –344C>T and –95T>C, and FCER1B 
–109T>C common variants was done by poly‑
merase chain reaction amplification and restric‑
tion enzyme digestion as described previously.11,12 
Diagnostic ANCA were detected and classified 
as perinuclear (p‑ANCA), cytoplasmic (c‑ANCA) 
or atypical‑flat c‑ANCA (a‑flat‑c‑ANCA) by indi‑
rect immunofluorescence (IIF, Euroimmun AG, 
Luebeck, Germany) using human neutrophils. 
Titer greater than 1:10 was considered positive. 
Specific auto antibodies against proteinase‑3 (an‑
ti‑PR3) or myeloperoxidase (anti‑MPO) were mea‑
sured by enzyme‑linked immunosorbent assay 
(ELISA) (Euroimmun AG, Luebeck, Germany). 
The threshold of 20 RU/ml was used for positive 
samples. Anti‑nuclear antibodies were detected 
table 1 Clinical and laboratory characteristics of the patients (n = 30)





lower respiratory tract involvement 18/n




neuro logical involvement 9/n
positive ANCA 26a/n
positive ANCA currently or in the past 30/n
positive anti‑PR3 21/n





CRP (mg/l) 4.33 (3.08–8.77)
C3c complement component (g/l) 1.26 (1.12–1.56)
C4 complement component (g/l) 0.28 (0.237–0.333)
logarithm of total serum IgE 1.73 ±0.49
Age and log‑transformed IgE are means ± standard deviations, other measurements 
are medians (25th–75th percentile)
a including 18 c‑ANCA (cytoplasmic), 3 p‑ANCA (perinuclear), 3 a‑flat‑c‑ANCA 
(atypical‑flat), 1 c‑ANCA/p‑ANCA and 1 c‑ANCA/p‑ANCA/a‑flat‑c‑ANCA cases
Abbreviations: aCCP – anti‑cyclic citrullinated peptide antibodies, ANA – anti‑nuclear 
antibodies, ANCA – anti‑neutrophil cytoplasmic antibodies, anti‑MPO – anti myelo‑
peroxidase antibodies, anti‑PR3 – anti‑proteinase‑3 antibodies,  
CRP – C‑reactive protein, IgE – immunoglobulin E, RF – rheumatoid factor
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be confirmed, new therapeutic modalities might 
be considered for WG, for example using anti‑IgE 
neutralizing antibodies.
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